Stock Report

Download full stock data and analysis for free Last Updated: 03-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Procter & Gamble Health Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: PGHL | BSE: 500126

₹5,669.50

up-down-arrow ₹-106.50 (-1.84%)

As on 02-Sep-2026IST

Market cap

info icon

₹9,427 Cr

Revenue (TTM)

info icon

₹1,433 Cr

P/E Ratio

info icon

26.4

P/B Ratio

info icon

15.3

Div. Yield

info icon

3.6 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -1.82 7.37 12.57 5.23 7.27
EBIT -27.69 10.22 14.27 14.20 15.38
Net Profit -23.39 9.50 10.85 13.24 13.51
EPS 1.64 45.29 18.73 15.86 15.08
Book Value -- -- -2.37 -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 26.2724.3630.8330.5032.30
Net Margin info 19.5018.5624.6122.8824.82
Return on equity info 42.5735.8358.2462.1844.15
Return on Capital info 57.8248.19--84.8658.05
Return on Assets info 22.0316.9143.6441.6530.85
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
84.86
58.05
42.52
46.07
Peer Median
--
19.41
21.76
21.89
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

58.24

Higher than Peers by 42.95

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
58.24
62.18
44.15
31.58
33.94
Peer Median
15.28
17.16
17.93
16.42
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

43.64

Higher than Peers by 33.34

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
43.64
41.65
30.85
13.43
11.00
Peer Median
10.30
9.89
12.81
12.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

30.83

Higher than Peers by 13.00

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
30.83
30.50
32.30
24.20
24.12
Peer Median
17.82
18.57
18.93
21.21
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

24.61

Higher than Peers by 10.23

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
24.61
22.88
24.82
17.22
18.39
Peer Median
14.38
13.27
14.94
15.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
22.36
24.40
18.14
19.39
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

12.57

Higher than Peers by 0.50

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
12.57
50.72
-18.86
-6.37
10.34
Peer Median
12.07
12.57
10.90
12.68
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

14.27

Lower than Peers by 7.69

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
14.27
42.32
--
-6.06
23.27
Peer Median
21.96
14.32
15.01
20.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

10.85

Lower than Peers by 13.69

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
10.85
39.46
16.63
-12.42
19.19
Peer Median
24.54
11.38
14.80
24.56
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

18.73

Lower than Peers by 1.55

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
18.73
39.46
16.63
-12.42
19.19
Peer Median
20.28
12.04
14.27
25.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
-2.37
0.45
-28.71
21.97
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
--
--
--
--
Peer Median
0.01
0.05
0.06
0.03
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.18

Higher than Peers by 0.23

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
2.18
2.18
2.44
2.39
1.72
Peer Median
1.95
1.90
1.90
2.23
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.65

Higher than Peers by 0.18

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
1.65
1.65
1.94
1.90
1.53
Peer Median
1.46
1.45
1.46
1.59
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

860.95

Higher than Peers by 842.16

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
860.95
818.93
725.70
380.61
409.05
Peer Median
18.79
19.02
24.96
45.29
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

11.46

Lower than Peers by 10.08

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
11.46
11.67
15.56
7.41
9.41
Peer Median
21.54
19.89
21.77
20.15
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.75

Higher than Peers by 1.03

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
1.75
2.00
1.35
0.84
0.64
Peer Median
0.72
0.78
0.76
0.79
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
36.06
40.92
29.14
27.36
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
28.65
38.75
35.37
34.37
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
181.85
235.41
223.07
206.35
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
--
-117.14
-155.74
-158.56
-144.61
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

26.41

Lower than Peers by 7.56

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
26.41
24.36
36.42
41.71
37.97
Peer Median
33.97
34.14
26.81
37.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

15.31

Higher than Peers by 10.51

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
15.31
15.33
16.04
15.83
11.73
Peer Median
4.80
5.48
4.65
5.51
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

3.61

Higher than Peers by 3.13

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
3.61
4.27
2.43
5.15
1.81
Peer Median
0.48
0.52
0.61
0.39
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

19.13

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
19.13
16.41
25.39
25.30
24.12
Peer Median
--
29.24
27.02
32.31
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

9,427

Lower than Peers by 8,729

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Jun-24
Jun-23
Procter & Gamble Health
9,427
7,965
8,536
8,383
8,714
Peer Median
18,156
17,919
20,914
24,063
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...